Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
出版年份 2022 全文链接
标题
Mass Spectrometry for Neurobiomarker Discovery: The Relevance of Post-Translational Modifications
作者
关键词
-
出版物
Cells
Volume 11, Issue 8, Pages 1279
出版商
MDPI AG
发表日期
2022-04-09
DOI
10.3390/cells11081279
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Beginner’s Guide to O-GlcNAc: From Nutrient Sensitive Pathway Regulation to Its Impact on the Immune System
- (2022) Michael P. Mannino et al. Frontiers in Immunology
- Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
- (2022) Emma Nichols et al. Lancet Public Health
- Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
- (2021) Carolina Alquezar et al. Frontiers in Neurology
- Glymphatic System as a Gateway to Connect Neurodegeneration From Periphery to CNS
- (2021) Gianfranco Natale et al. Frontiers in Neuroscience
- In-depth site-specific analysis of N-glycoproteome in human cerebrospinal fluid (CSF) and glycosylation landscape changes in Alzheimer's disease (AD)
- (2021) Zhengwei Chen et al. MOLECULAR & CELLULAR PROTEOMICS
- Amyloid Positivity in the Alzheimer/Subcortical-Vascular Spectrum
- (2021) Sung Hoon Kang et al. NEUROLOGY
- Post-translational modifications: Regulators of neurodegenerative proteinopathies
- (2021) Rohan Gupta et al. AGEING RESEARCH REVIEWS
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- Biomarkers for neurodegenerative diseases
- (2021) Oskar Hansson NATURE MEDICINE
- What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease?
- (2021) Stefan Gaunitz et al. Biomolecules
- P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
- (2021) Juan Lantero‐Rodriguez et al. EMBO Molecular Medicine
- The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
- (2021) Giovanni B. Frisoni et al. NATURE REVIEWS NEUROSCIENCE
- Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
- (2021) Sherif Bayoumy et al. Alzheimers Research & Therapy
- Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
- (2021) Lei Yu et al. Frontiers in Aging Neuroscience
- Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications
- (2020) T Kissel et al. ANNALS OF THE RHEUMATIC DISEASES
- Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains
- (2020) Tamta Arakhamia et al. CELL
- Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer’s Disease
- (2020) Patrick Oeckl et al. JOURNAL OF PROTEOME RESEARCH
- Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
- (2020) Pawel Obrocki et al. Alzheimers Research & Therapy
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. NATURE MEDICINE
- Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- (2020) Shorena Janelidze et al. Nature Communications
- Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
- (2020) Nicolas R. Barthélemy et al. Alzheimers Research & Therapy
- Relevance of biomarkers across different neurodegenerative diseases
- (2020) Alexander J. Ehrenberg et al. Alzheimers Research & Therapy
- Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease
- (2020) Nicolas R. Barthélemy et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Incremental Value of CSF Biomarkers in Clinically Diagnosed AD and Non-AD Dementia
- (2020) Jean-Baptiste Oudart et al. Frontiers in Neurology
- Phosphorylated tau interactome in the human Alzheimer’s disease brain
- (2020) Eleanor Drummond et al. BRAIN
- The N‐glycan profile in cortex and hippocampus is altered in Alzheimer disease
- (2020) Stefan Gaunitz et al. JOURNAL OF NEUROCHEMISTRY
- Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
- (2020) Sruti Rayaprolu et al. NEUROPSYCHOPHARMACOLOGY
- Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease
- (2020) Lingyan Ping et al. Scientific Data
- Detection and Quantification of Novel C‐terminal TDP‐43 Fragments in ALS‐TDP
- (2020) Emily Feneberg et al. BRAIN PATHOLOGY
- Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
- (2020) Hendrik Wesseling et al. CELL
- Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study
- (2020) Lu-Lu Bu et al. Frontiers in Aging Neuroscience
- Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale
- (2020) Nicolas Ruffini et al. Cells
- Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated
- (2019) Heidi Olzscha BIOLOGICAL CHEMISTRY
- Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
- (2019) Payel Bhattacharjee et al. JOURNAL OF PROTEOME RESEARCH
- Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer’s Disease
- (2019) Nicolas R. Barthélemy et al. Frontiers in Aging Neuroscience
- Analysis and Interpretation of Protein Post-Translational Modification Site Stoichiometry
- (2019) Gabriela Prus et al. TRENDS IN BIOCHEMICAL SCIENCES
- The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
- (2019) Mroczko et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- N-Glycan Profile of Cerebrospinal Fluids from Alzheimer’s Disease Patients Using Liquid Chromatography with Mass Spectrometry
- (2019) Byeong Gwan Cho et al. JOURNAL OF PROTEOME RESEARCH
- Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer’s Disease
- (2019) Carol J. Huseby et al. JOURNAL OF ALZHEIMERS DISEASE
- Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
- (2019) Takashi Kasai et al. Annals of Clinical and Translational Neurology
- On-line Aptamer Affinity Solid-Phase Extraction Capillary Electrophoresis-Mass Spectrometry for the Analysis of Blood α-Synuclein
- (2019) Roger Pero-Gascon et al. ANALYTICAL CHEMISTRY
- Role of Post‐translational Modifications in Alzheimer's Disease
- (2019) Madhu Ramesh et al. CHEMBIOCHEM
- Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
- (2018) John L Robinson et al. BRAIN
- Precision Profiling of the Cardiovascular Post-Translationally Modified Proteome
- (2018) Justyna Fert-Bober et al. CIRCULATION RESEARCH
- Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry
- (2018) Philipp Mertins et al. Nature Protocols
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Integrating Proteomics and Targeted Metabolomics to Understand Global Changes in Histone Modifications
- (2018) Johayra Simithy et al. PROTEOMICS
- Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease
- (2018) Lingyan Ping et al. Scientific Data
- Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease
- (2018) Measho H. Abreha et al. PROTEOMICS
- Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
- (2018) Claudia Cicognola et al. ACTA NEUROPATHOLOGICA
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression
- (2017) Li Yang et al. Proteomics Clinical Applications
- Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- (2017) Michael G. Erkkinen et al. Cold Spring Harbor Perspectives in Biology
- Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain
- (2017) Norelle C. Wildburger et al. Scientific Reports
- FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease
- (2016) Waltraud Mair et al. ANALYTICAL CHEMISTRY
- Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity
- (2016) Nicolas R Barthélemy et al. JOURNAL OF PROTEOME RESEARCH
- Native Mass Spectrometry: What is in the Name?
- (2016) Aneika C. Leney et al. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Alpha-, Beta-, and Gamma-synuclein Quantification in Cerebrospinal Fluid by Multiple Reaction Monitoring Reveals Increased Concentrations in Alzheimer′s and Creutzfeldt-Jakob Disease but No Alteration in Synucleinopathies
- (2016) Patrick Oeckl et al. MOLECULAR & CELLULAR PROTEOMICS
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- Neurodegenerative diseases
- (2016) Marie-Thérèse Heemels NATURE
- The road to restoring neural circuits for the treatment of Alzheimer's disease
- (2016) Rebecca G. Canter et al. NATURE
- Ageing, neurodegeneration and brain rejuvenation
- (2016) Tony Wyss-Coray NATURE
- Defects in trafficking bridge Parkinson's disease pathology and genetics
- (2016) Asa Abeliovich et al. NATURE
- Advances in mass spectrometry-based clinical biomarker discovery
- (2016) Christopher A. Crutchfield et al. Clinical Proteomics
- Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
- (2016) Fuyuki Kametani et al. Scientific Reports
- Neuroproteomics tools in clinical practice
- (2015) Ganna Shevchenko et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations
- (2015) Özlem Önder et al. Expert Review of Proteomics
- Current strategies and findings in clinically relevant post-translational modification-specific proteomics
- (2015) Oliver Pagel et al. Expert Review of Proteomics
- Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry
- (2015) Navin Rauniyar INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
- (2015) Sang-Won Min et al. NATURE MEDICINE
- Multidimensional proteomics for cell biology
- (2015) Mark Larance et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Using data-independent, high-resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications
- (2015) Tatjana Sajic et al. Proteomics Clinical Applications
- Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid
- (2015) Arnaud Goyallon et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation
- (2015) Yifan Wang et al. Scientific Reports
- Mechanisms of amyloid fibril formation
- (2015) N. V. Dovidchenko et al. BIOCHEMISTRY-MOSCOW
- Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity
- (2014) Kristen E. Funk et al. BIOCHEMICAL JOURNAL
- Enrichment and separation techniques for large-scale proteomics analysis of the protein post-translational modifications
- (2014) Junfeng Huang et al. JOURNAL OF CHROMATOGRAPHY A
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
- (2014) Peter V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
- (2014) John F. Kellie et al. Scientific Reports
- Post-translational Modifications and Mass Spectrometry Detection
- (2013) André M.N. Silva et al. FREE RADICAL BIOLOGY AND MEDICINE
- Proteoform: a single term describing protein complexity
- (2013) Lloyd M Smith et al. NATURE METHODS
- Large-scale identification of ubiquitination sites by mass spectrometry
- (2013) Namrata D Udeshi et al. Nature Protocols
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid
- (2012) Gunnar Brinkmalm et al. JOURNAL OF MASS SPECTROMETRY
- Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
- (2012) Scott A Yuzwa et al. Nature Chemical Biology
- Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
- (2012) Magdalena Nutu et al. NEUROMOLECULAR MEDICINE
- Parkinson's Disease: Genetics and Pathogenesis
- (2011) Joshua M. Shulman et al. Annual Review of Pathology-Mechanisms of Disease
- Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- (2011) Penelope G. Foulds et al. FASEB JOURNAL
- Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome
- (2011) Woong Kim et al. MOLECULAR CELL
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid -peptides in human cerebrospinal fluid
- (2011) A. Halim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanding the proteome: disordered and alternatively folded proteins
- (2011) H. Jane Dyson QUARTERLY REVIEWS OF BIOPHYSICS
- Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits -Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
- (2010) K. E. Paleologou et al. JOURNAL OF NEUROSCIENCE
- Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling
- (2010) Guoqiang Xu et al. NATURE BIOTECHNOLOGY
- Decoding signalling networks by mass spectrometry-based proteomics
- (2010) Chunaram Choudhary et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
- (2010) Kaj Blennow et al. Nature Reviews Neurology
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- O-GlcNAc cycling: Implications for neurodegenerative disorders
- (2009) Brooke D. Lazarus et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Modification-specific proteomics: Strategies for characterization of post-translational modifications using enrichment techniques
- (2009) Yingming Zhao et al. PROTEOMICS
- A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
- (2008) Scott A Yuzwa et al. Nature Chemical Biology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started